(Q77953399)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Systemic immune response after intravesical instillation of bacille Calmette-Guérin (BCG) for superficial bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

main subject

systemic immune response

1 reference

K Taniguchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Koga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Nishikido

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Yamashita

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T Sakuragi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

H Kanetake

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Y Saito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

131-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha

9 December 2019

cites work

1 reference

12 December 2020

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

1 reference

12 December 2020

Current perspectives on diagnosis and treatment of superficial bladder cancer

1 reference

12 December 2020

Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall

1 reference

12 December 2020

Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy

1 reference

12 December 2020

Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy

1 reference

12 December 2020

Immune interferon: a pleiotropic lymphokine with multiple effects

1 reference

12 December 2020

Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancer

1 reference

12 December 2020

BCG induced killer cell activity.

1 reference

12 December 2020

Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG

1 reference

12 December 2020

Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin

1 reference

12 December 2020

Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: lack of a role of natural killer cells

1 reference

12 December 2020

Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity

1 reference

12 December 2020

Bladder cancer immunotherapy

1 reference

12 December 2020

BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line

1 reference

12 December 2020

Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy

1 reference

12 December 2020

Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy

1 reference

12 December 2020

Peripheral blood lymphocyte response in patients with superficial transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guérin--a useful marker of response?

1 reference

12 December 2020

Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value

1 reference

12 December 2020

Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer

1 reference

12 December 2020

10.1046/J.1365-2249.1999.00756.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933432%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference